Laxative

Product NDC: 41163-245
11-digit product format: 411630245
Labeler code: 41163
Product ID: 41163-245_e080993a-4908-439c-af00-5bbe23c408bc
Type: HUMAN OTC DRUG
Nonproprietary name: Sennosides
Dosage form: TABLET
Route: ORAL
Labeler: EQUALINE (SuperValu)
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2014-12-31
Marketing end: 2020-12-31
Substance: SENNOSIDES
Active strength: 25 mg/1
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	41163-245		D	Discontinued by firm	2026-10-15
excluded package	package	41163-245	41163-245-24	D	Discontinued by firm	2026-10-15
excluded package	package	41163-245	41163-245-48	D	Discontinued by firm	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	41163-245-48	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	41163-245-24	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41163-245-48	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41163-245-24	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41163-245-48	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41163-245-24	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41163-245-48	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41163-245-24	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41163-245-48	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41163-245-24	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41163-245-48	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41163-245-24	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41163-245-48	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41163-245-24	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41163-245-48	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41163-245-24	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41163-245-48	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41163-245-24	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	41163-245-48	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	41163-245-24	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	41163-245-48	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	41163-245-24	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	41163-245-48	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	41163-245-24	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
41163-245-24	EA - Each	41163-245	8a39ada7-be61-4613-ac08-3227c6d88d60	1	2017-03-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SENNOSIDES	ACTIVE INGREDIENT	3FYP5M0IJX	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
ACACIA	INACTIVE INGREDIENT	5C5403N26O	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
CALCIUM SULFATE ANHYDROUS	INACTIVE INGREDIENT	E934B3V59H	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
KAOLIN	INACTIVE INGREDIENT	24H4NWX5CO	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
SHELLAC	INACTIVE INGREDIENT	46N107B71O	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1
TARTARIC ACID	INACTIVE INGREDIENT	W4888I119H	LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]	1

Laxative

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

DailyMed Billing Units#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#